6446 PharmaEssentia Corp.
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
PharmaEssentia Corp. (6446) announced important resolutions from the 2026 Annual General Meeting (acted by the board of directors) of its major subsidiary, Pan-Asia Medical Products Co., Ltd. These include the approval of the 2025 loss compensation plan and the 2025 financial and business reports.